Suppr超能文献

相似文献

4
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.
5
Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology.
Expert Opin Drug Saf. 2016 Jul;15(7):925-35. doi: 10.1080/14740338.2016.1177021. Epub 2016 May 3.
7
Standardized classification unsuitable for spontaneous reporting: the example of osteonecrosis of the jaw.
Expert Opin Drug Saf. 2015 Jul;14(7):1015-21. doi: 10.1517/14740338.2015.1044968. Epub 2015 May 5.
8
Bisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons.
J Rheumatol. 2011 Jul;38(7):1396-402. doi: 10.3899/jrheum.100221. Epub 2011 Apr 15.
9
The risk of osteonecrosis of the jaws in Taiwanese osteoporotic patients treated with oral alendronate or raloxifene.
J Clin Endocrinol Metab. 2014 Aug;99(8):2729-35. doi: 10.1210/jc.2013-4119. Epub 2014 Apr 23.
10
Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia.
J Oral Maxillofac Surg. 2007 Mar;65(3):415-23. doi: 10.1016/j.joms.2006.10.061.

引用本文的文献

2
A Case Report of Ibandronic Acid Induced Non-Exposed BRONJ Involving the Maxillary Sinus.
J Oral Maxillofac Res. 2023 Dec 31;14(4):e5. doi: 10.5037/jomr.2023.14405. eCollection 2023 Oct-Dec.
4
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate.
Autops Case Rep. 2020 Dec 8;11:e2020186. doi: 10.4322/acr.2020.186.
6
Imperatorin promotes osteogenesis and suppresses osteoclast by activating AKT/GSK3 β/β-catenin pathways.
J Cell Mol Med. 2020 Feb;24(3):2330-2341. doi: 10.1111/jcmm.14915. Epub 2019 Dec 28.

本文引用的文献

1
Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
Osteoporos Int. 2017 Mar;28(3):1145-1147. doi: 10.1007/s00198-016-3840-z. Epub 2016 Nov 20.
3
Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.
Curr Osteoporos Rep. 2016 Oct;14(5):219-25. doi: 10.1007/s11914-016-0318-z.
4
Bisphosphonate-related osteonecrosis of the jaw: data from the French national pharmacovigilance database.
Fundam Clin Pharmacol. 2016 Oct;30(5):450-8. doi: 10.1111/fcp.12211. Epub 2016 Jul 13.
5
BRONJ in patients with rheumatoid arthritis: a multicenter case series.
Oral Dis. 2016 Sep;22(6):543-8. doi: 10.1111/odi.12490. Epub 2016 May 27.
7
Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Oral Dis. 2016 May;22(4):324-9. doi: 10.1111/odi.12447. Epub 2016 Feb 26.
8
The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study.
Osteoporos Int. 2015 Dec;26(12):2773-83. doi: 10.1007/s00198-015-3234-7. Epub 2015 Jul 23.
10
Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
J Oral Maxillofac Surg. 2015 Jun;73(6):1095-105. doi: 10.1016/j.joms.2014.12.040. Epub 2015 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验